Clinical Trial Update: Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update evaluating the safety and efficacy of FTY720 (fingolimod) in adult kidney transplant recipients, conducted in Phase 2 and Phase 3 and now …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• FTY720 (fingolimod)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Kidney Transplantation | Phase 2, Phase 3 | Status: COMPLETED